Eventide Asset Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Eventide Asset Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-389	Closed	-$212K	–	131
2016 Q4	$212K	Sell	389 -880	-69%	-$434K	0.01%	128
2016 Q3	$675K	Hold	1,269	–	–	0.04%	111
2016 Q2	$1.17M	Hold	1,269	–	–	0.07%	102
2016 Q1	$2.04M	Hold	1,269	–	–	0.11%	101
2015 Q4	$1.98M	Buy	1,269 +6	+0.5%	+$11.7K	0.1%	101
2015 Q3	$3.5M	Buy	1,263 +8	+0.6%	+$44.9K	0.2%	86
2015 Q2	$6.37M	Buy	1,255 +71	+6%	+$439K	0.34%	69
2015 Q1	$8.38M	Buy	+1,184	New	+$8.88M	0.63%	59

Other funds holding ZSAN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Eventide Asset Management's ZSAN Position: Q1 2017 in Review

Eventide Asset Management sold out of Zosano Pharma Corporation (ZSAN) in Q1 2017, closing a stake of 389 shares — an estimated $212K sold.

Eventide Asset Management first reported a position in ZSAN in Q1 2015 and held it in 8 quarters. The position peaked at $8.38M in Q1 2015. 26 funds tracked by Wall St. Rank hold ZSAN as of Q1 2017.

Eventide Asset Management reported no remaining Zosano Pharma Corporation position as of Q1 2017 after selling out during the quarter.
Eventide Asset Management sold 389 Zosano Pharma Corporation shares in Q1 2017, an estimated $212K.
Eventide Asset Management first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 8 quarters.
Eventide Asset Management's Zosano Pharma Corporation position peaked at $8.38M in Q1 2015.
26 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2017.

Based on Eventide Asset Management's 13F filing for Q1 2017, filed 15 May 2017.